Maintaining ‘standards’ for biosimilar monoclonal antibodies

被引：0
|
作者：
Sandra Prior
Clive Metcalfe
Simon E. Hufton
Meenu Wadhwa
Christian K. Schneider
Chris Burns
机构：
[1] National Institute for Biological Standards and Control (NIBSC),
[2] Twincore Centre,undefined
[3] Hannover Medical School,undefined
来源：
Nature Biotechnology | 2021年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：276 / 280
页数：4
相关论文
共 50 条
  • [21] Biosimilar monoclonal antibodies: Challenges and approaches towards formulation
    Goli, Venkata Appa Reddy
    Butreddy, Arun
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 366
  • [22] Expert perspectives on biosimilar monoclonal antibodies in breast cancer
    Cortes, J.
    Curigliano, G.
    Dieras, V.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (02) : 233 - 239
  • [23] Biosimilar monoclonal antibodies: a science-based regulatory challenge
    Declerck, Paul J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (02) : 153 - 156
  • [24] EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
    Francescon, Sara
    Fornasier, Giulia
    Baldo, Paolo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (04) : 778 - 782
  • [25] Investigation of Immunogenicity Assessment of Biosimilar Monoclonal Antibodies in the United States
    Cheng, Ching-An
    Jiang, Ai-Lei
    Liu, Yu-Ru
    Chang, Lin-Chau
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1274 - 1284
  • [26] Effects of thermal treatment on quality of biosimilar and originator monoclonal antibodies
    Erdemgil, Yigit
    Yamaci, Merve celik
    Pamukcu, Ceren
    Unalp, Fulya
    Keles, Zeynep Zuelfiye Yildirim
    Atik, Ahmet Emin
    Serdar, Muhittin Abdulkadir
    ADVANCES IN SAMPLE PREPARATION, 2024, 10
  • [27] Biosimilar monoclonal antibodies: comparative study of analytical and functional quality
    Beck, Alain
    Guillarme, Davy
    Fleury-Souverain, Sandrine
    Bodier-Montagutelli, Elsa
    Respaud, Renaud
    M S-MEDECINE SCIENCES, 2020, 35 (12): : 1146 - 1152
  • [28] EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
    Sara Francescon
    Giulia Fornasier
    Paolo Baldo
    International Journal of Clinical Pharmacy, 2018, 40 : 778 - 782
  • [29] The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
    Barbier, Liese
    Declerck, Paul
    Simoens, Steven
    Neven, Patrick
    Vulto, Arnold G.
    Huys, Isabelle
    BRITISH JOURNAL OF CANCER, 2019, 121 (03) : 199 - 210
  • [30] The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
    Liese Barbier
    Paul Declerck
    Steven Simoens
    Patrick Neven
    Arnold G. Vulto
    Isabelle Huys
    British Journal of Cancer, 2019, 121 : 199 - 210
12345